Hagemann C - Search Results

1

Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood-Brain Barrier In Vitro and In Vivo.

Salvador E, Kessler AF, Domröse D, Hörmann J, Schaeffer C, Giniunaite A, Burek M, Tempel-Brami C, Voloshin T, Volodin A, Zeidan A, Giladi M, Ernestus RI, Löhr M, Förster CY, Hagemann C. Salvador E, et al. Among authors: hagemann c. Biomolecules. 2022 Sep 22;12(10):1348. doi: 10.3390/biom12101348. Biomolecules. 2022. PMID: 36291557 Free PMC article.

2

Egr-1 is not upregulated in response to hypoxic and oxygenation conditions in human glioblastoma in vitro.

Said HM, Polat B, Hagemann C, Vince GH, Anacker J, K Mmerer U, Flentje M, Vordermark D. Said HM, et al. Among authors: hagemann c. Mol Med Rep. 2009 Sep-Oct;2(5):757-63. doi: 10.3892/mmr_00000169. Mol Med Rep. 2009. PMID: 21475898

3

Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.

Said HM, Staab A, Hagemann C, Vince GH, Katzer A, Flentje M, Vordermark D. Said HM, et al. Among authors: hagemann c. J Neurooncol. 2007 Jan;81(1):27-38. doi: 10.1007/s11060-006-9205-2. Epub 2006 Aug 31. J Neurooncol. 2007. PMID: 16944313

4

MEKK3 interacts with the PA28 gamma regulatory subunit of the proteasome.

Hagemann C, Patel R, Blank JL. Hagemann C, et al. Biochem J. 2003 Jul 1;373(Pt 1):71-9. doi: 10.1042/BJ20021758. Biochem J. 2003. PMID: 12650640 Free PMC article.

5

The regulatory subunit of protein kinase CK2 is a specific A-Raf activator.

Hagemann C, Kalmes A, Wixler V, Wixler L, Schuster T, Rapp UR. Hagemann C, et al. FEBS Lett. 1997 Feb 17;403(2):200-2. doi: 10.1016/s0014-5793(97)00011-2. FEBS Lett. 1997. PMID: 9042966 Free article.

6

Isotype-specific functions of Raf kinases.

Hagemann C, Rapp UR. Hagemann C, et al. Exp Cell Res. 1999 Nov 25;253(1):34-46. doi: 10.1006/excr.1999.4689. Exp Cell Res. 1999. PMID: 10579909 Review.

7

Interaction between the protein kinase B-Raf and the alpha-subunit of the 11S proteasome regulator.

Kalmes A, Hagemann C, Weber CK, Wixler L, Schuster T, Rapp UR. Kalmes A, et al. Among authors: hagemann c. Cancer Res. 1998 Jul 15;58(14):2986-90. Cancer Res. 1998. PMID: 9679960

8

Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood.

Mühlisch J, Schwering A, Grotzer M, Vince GH, Roggendorf W, Hagemann C, Sörensen N, Rickert CH, Osada N, Jürgens H, Frühwald MC. Mühlisch J, et al. Among authors: hagemann c. Oncogene. 2006 Feb 16;25(7):1111-7. doi: 10.1038/sj.onc.1209137. Oncogene. 2006. PMID: 16186793

9

Regulation of glycolysis by Raf protein serine/threonine kinases.

Le Mellay V, Houben R, Troppmair J, Hagemann C, Mazurek S, Frey U, Beigel J, Weber C, Benz R, Eigenbrodt E, Rapp UR. Le Mellay V, et al. Among authors: hagemann c. Adv Enzyme Regul. 2002;42:317-32. doi: 10.1016/s0065-2571(01)00036-x. Adv Enzyme Regul. 2002. PMID: 12123723 No abstract available.

10

[Spontaneous intracranial hypotension with brain sagging and reversible frontotemporal dementia : Case report and review of the literature].

Hagemann C, Christ M, Maurer C, Wegerer H, Naumann M, Bayas A. Hagemann C, et al. Nervenarzt. 2022 Oct;93(10):1049-1052. doi: 10.1007/s00115-022-01280-8. Epub 2022 Apr 1. Nervenarzt. 2022. PMID: 35362722 Free PMC article. Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page